Copyright
©The Author(s) 2016.
World J Hepatol. Feb 18, 2016; 8(5): 265-272
Published online Feb 18, 2016. doi: 10.4254/wjh.v8.i5.265
Published online Feb 18, 2016. doi: 10.4254/wjh.v8.i5.265
Vascular | Hepatic artery thrombosis |
Portal hypertension bilopathy | |
Portal cavernoma associated cholangiopathy | |
Intra-arterial chemotherapy | |
Sickle cell disease related cholangiopathy | |
Trauma | Trauma post cholecystectomy |
Abdominal trauma | |
Infections | AIDS related cholangiopathy |
Recurrent pyogenic cholangitis | |
Benign | Intraductal stone disease |
Malignancy | Cholangiocarcinoma |
Autoimmune | Autoimmune sclerosing cholangitis |
IgG4 related sclerosing cholangitis | |
Systemic vasculitis | |
Other | Recurrent pancreatitis |
Sclerosing cholangitis in critically ill patient | |
TPN related cholangiopathy | |
Histocytosis X |
- Citation: Nayagam JS, Pereira SP, Devlin J, Harrison PM, Joshi D. Controversies in the management of primary sclerosing cholangitis. World J Hepatol 2016; 8(5): 265-272
- URL: https://www.wjgnet.com/1948-5182/full/v8/i5/265.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i5.265